Close

Rating History for Sarepta Therapeutics (SRPT) by Leerink Partners

More Stocks Rated by Leerink Partners | Latest Ratings for SRPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/17/2022 Mani Foroohar Maintain Outperform
(N/A)		 145.00
(126.00)		  
 		   Details